Selective ultrasonic focusing towards an optical contrast agent by use of photoacoustic‐guided time‐reversal

2008 ◽  
Vol 123 (5) ◽  
pp. 3640-3640 ◽  
Author(s):  
Arik R. Funke ◽  
Emmanuel Bossy ◽  
Jean‐François Aubry ◽  
Mathias Fink ◽  
Albert‐Claude Boccara
Keyword(s):  
Contrast Agent ◽  
Time Reversal ◽  
Optical Contrast ◽  
Optical Contrast Agent

scholarly journals Laser-induced photoacoustic tomography enhanced with an optical contrast agent

2004 ◽  
Author(s):  
Xueding Wang ◽  
Geng Ku ◽  
Xueyi Xie ◽  
Malgorzata A. Wegiel ◽  
Darryl J. Bornhop ◽  
...  
Keyword(s):  
Contrast Agent ◽  
Photoacoustic Tomography ◽  
Optical Contrast ◽  
Optical Contrast Agent

scholarly journals A multimeric MR-optical contrast agent for multimodal imaging

2014 ◽  
Vol 50 (78) ◽  
pp. 11469-11471 ◽  
Author(s):  
Victoria S. R. Harrison ◽  
Christiane E. Carney ◽  
Keith W. Macrenaris ◽  
Thomas J. Meade
Keyword(s):  
Contrast Agent ◽  
Multimodal Imaging ◽  
Optical Contrast ◽  
Design Synthesis ◽  
Optical Contrast Agent

We describe the design, synthesis and in vitro evaluation of a multimodal and multimeric contrast agent.

scholarly journals Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling

2007 ◽  
Vol 2 ◽  
pp. 117727190700200 ◽  
Author(s):  
Julie M. Kneller ◽  
Thomas Ehlen ◽  
Jasenka P. Matisic ◽  
Dianne Miller ◽  
Dirk Van Niekerk ◽  
...  
Keyword(s):  
Gene Expression ◽  
Cell Surface ◽  
Contrast Agent ◽  
Expression Profiles ◽  
Physiological State ◽  
Disease Process ◽  
Intraepithelial Neoplasia ◽  
Surface Proteins ◽  
Optical Contrast ◽  
Optical Contrast Agent

Sixteen longSAGE libraries from four different clinical stages of cervical intraepithelial neoplasia have enabled us to identify novel cell-surface biomarkers indicative of CIN stage. By comparing gene expression profiles of cervical tissue at early and advanced stages of CIN, several genes are identified to be novel genetic markers. We present fifty-six cell-surface gene products differentially expressed during progression of CIN. These cell surface proteins are being examined to establish their capacity for optical contrast agent binding. Contrast agent visualization will allow real-time assessment of the physiological state of the disease process bringing vast benefit to cancer care. The data discussed in this publication have been submitted to NCBIs Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/ ) and are accessible through GEO Series accession number GSE6252.

In-vivo optical contrast agent dynamics in tumors with MRI co-registration

2003 ◽  
Author(s):  
David J. Cuccia ◽  
Fred Bevilacqua ◽  
Anthony J. Durkin ◽  
Bruce J. Tromberg ◽  
Gultekin Gulsen ◽  
...  
Keyword(s):  
Contrast Agent ◽  
Optical Contrast ◽  
Optical Contrast Agent

scholarly journals Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG)

2008 ◽  
Vol 10 (2) ◽  
Author(s):  
Alexander Wall ◽  
Thorsten Persigehl ◽  
Peter Hauff ◽  
Kai Licha ◽  
Michael Schirner ◽  
...  
Keyword(s):  
Contrast Agent ◽  
Human Cancer ◽  
Optical Contrast ◽  
Optical Contrast Agent

Novel design of multimodal MRI/NIR optical contrast agent

2011 ◽  
Author(s):  
Kevin Guo ◽  
Franck Lin ◽  
Walter Akers ◽  
Jie Zheng ◽  
Bao Teng ◽  
...  
Keyword(s):  
Contrast Agent ◽  
Optical Contrast ◽  
Optical Contrast Agent ◽  
Multimodal Mri ◽  
Novel Design
Sign in / Sign up

Export Citation Format

Share Document